thumb image

Oncolytic Virotherapy Summit

5 – 6 December 2017, San Diego, USA

The Annual Oncolytic Virotherapy Summit is dedicated to foster the next wave of genetically modified viruses that target, replicate and kill cancer cells in a clinical setting, spurred on by advanced genetic engineering techniques.

By better understanding oncolytic platforms, preclinical virotherapy models, clinical strategy and scalable manufacture of viruses, Oncolytic Virotherapy Summit is the only industry-focused gathering allowing you to capitalize on this inflection point and enhance the translation of innovative basic research into the next generation of clinically-relevant virotherapeutics.

Vibalogics will be attending this event between 5 – 6 December 2017 and look forward to see you there! For more information on this event, please see the website